L1 Capital Pty LTD Arrowhead Pharmaceuticals, Inc. Transaction History

L1 Capital Pty LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $11.6 Million - $20.5 Million	-292,735 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $300,906 - $427,401	-5,180 Reduced 1.74%	292,735 $19.4 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $110,396 - $160,659	1,891 Added 0.64%	297,915 $18.6 Million
Q1 2021 May 07, 2021	SELL	$61.35 - $90.47 $163,375 - $240,921	-2,663 Reduced 0.89%	296,024 $19.6 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $2.89 Million - $5.63 Million	-65,949 Reduced 18.09%	298,687 $23.1 Million
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $9.75 Million - $15 Million	293,437 Added 412.14%	364,636 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $1.86 Million - $3.08 Million	71,199 New	71,199 $3.08 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of L1 Capital Pty LTD, based on Form 13F filings with the SEC.

Stay updated on L1 Capital Pty LTD with notifications on news.